Literature DB >> 7188699

Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens.

K Ozato, N Mayer, D H Sachs.   

Abstract

Hybridoma cell lines secreting antibodies to mouse H-2 or Ia antigens have been generated by fusing mouse immune lymphocytes with appropriate myeloma lines. Among the 11 established clones reported here, nine produce anti-H-2 antibodies and two produce anti-Ia antibodies. The specificities and cross-reactions of these monoclonal antibodies have been studied in detail. One hybridoma antibody reacted only to Kk antigens without any detectable cross-reactions, thus suggesting reaction to a private specificity of the Kk molecule. All other anti-H-2 hybridoma antibodies appeared to detect public specificities as defined either by reactions with products of more than one H-2 locus or with different alleles at one or more loci. The two anti-Ia antibodies both reacted with I-E/C products, but exhibited different cross-reactivity patterns. Strain distribution analyses so far indicate that the public specificities detected by these monoclonal antibodies are considerably different from those that had been established by traditional serology. Since public specificities defined by the hybridoma antibodies must by definition represent cross-reactions, these findings may have important implications relating to the structure and evolution of MHC gene products.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7188699

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  320 in total

1.  Alternative proteolytic processing of mouse mammary tumor virus superantigens.

Authors:  F Denis; N H Shoukry; M Delcourt; J Thibodeau; N Labrecque; H McGrath; J S Munzer; N G Seidah; R P Sékaly
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  T cell-independent rescue of B lymphocytes from peripheral immune tolerance.

Authors:  V Kouskoff; G Lacaud; D Nemazee
Journal:  Science       Date:  2000-03-31       Impact factor: 47.728

3.  B cell receptor expression level determines the fate of developing B lymphocytes: receptor editing versus selection.

Authors:  V Kouskoff; G Lacaud; K Pape; M Retter; D Nemazee
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

4.  Differing processing requirements of four recombinant antigens containing a single defined T-cell epitope for presentation by major histocompatibility complex class II.

Authors:  L Colledge; M Y Sun ; W Lin; C C Blackburn; P A Reay
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

5.  Altered positive selection due to corecognition of floppy peptide/MHC II conformers supports an integrative model of thymic selection.

Authors:  Christophe Viret; Xin He; Charles A Janeway
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-16       Impact factor: 11.205

6.  Model for the interaction of gammaherpesvirus 68 RING-CH finger protein mK3 with major histocompatibility complex class I and the peptide-loading complex.

Authors:  Xiaoli Wang; Lonnie Lybarger; Rose Connors; Michael R Harris; Ted H Hansen
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

7.  CD4-CD8+ T-cell receptor-alpha beta+ major histocompatibility complex class-II-specific T-cell clones isolated from aged athymic mice.

Authors:  K Yui; M I Greene
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

8.  The B144-H-2Db interval and the location of a mouse homologue of the human D6S81E locus.

Authors:  J M Wroblewski; S G Kaminsky; V K Milisauskas; A M Pittman; D D Chaplin; T Spies; I Nakamura
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

9.  Prevention of diabetes in nonobese diabetic mice by anti-I-A monoclonal antibodies: transfer of protection by splenic T cells.

Authors:  C Boitard; A Bendelac; M F Richard; C Carnaud; J F Bach
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

10.  Expression of T-cell associated antigens by porcine natural killer cells.

Authors:  M D Pescovitz; M A Lowman; D H Sachs
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.